Security key
67576A100
OCULAR THERAPEUTIX, INC - Common Stock (OCUL)
CUSIP: 67576A100
Q4 2017 13F Holders as of 31 Dec 2017
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 13,505,162
- Total 13F value
- $60,113,388
- Share change
- -2,078,730
- Put/Call ratio
- 130%
- SEC-reported price per share
- $4.45
- Number of holders
- 67
- Value change
- -$11,835,912
- Number of buys
- 25
- Number of sells
- 38
- Shares outstanding
- 217,539,543
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2017
Institutions
67
Top holders
10
OCUL full security history
Ownership snapshot
Full 13F holder table
OCULAR THERAPEUTIX, INC SEC filings
OCULAR THERAPEUTIX, INC company facts
Broader feeds
Ownership snapshot
Top reported holders of OCUL - OCULAR THERAPEUTIX, INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Versant Venture Managemen...
Disclosed value leader
Versant Venture Managemen...
Comparable rows
15/15
Latest evidence
30 Sep 2017
13F
Lead comparable stake: 1%
Showing 1-6 of 15 holder rows.
Quick read
Versant Venture Management, LLC leads the comparable SEC ownership view at 1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Versant Venture Management, LLC's linked filing trail.
Comparable ownership
Top 5
Versant Venture Management, LLC
1%
JENNISON ASSOCIATES LLC
0.91%
SV Health Investors, LLC
0.74%
BlackRock Finance, Inc.
0.65%
WELLINGTON MANAGEMENT GROUP LLP
0.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Versant Venture Management, LLC |
13F
Company
|
1%
|
$13,846,150
2,215,384 shares
|
— | 30 Sep 2017 |
| JENNISON ASSOCIATES LLC |
13F
Company
|
0.91%
|
$12,203,000
1,974,636 shares
|
— | 30 Sep 2017 |
| SV Health Investors, LLC |
13F
Company
|
0.74%
|
$9,920,000
1,605,207 shares
|
— | 30 Sep 2017 |
| BlackRock Finance, Inc. |
13F
Company
|
0.65%
|
$8,696,000
1,407,284 shares
|
— | 30 Sep 2017 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
0.6%
|
$8,129,000
1,315,265 shares
|
— | 30 Sep 2017 |
| FMR LLC |
13F
Company
|
0.59%
|
$7,922,000
1,281,799 shares
|
— | 30 Sep 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
67
Shares
13,505,162
Rows available
67
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
71
Q4 2017 holders
67
Holder diff
-4
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 value | Q4 2017 value | Value change | Value Chg % |
|---|